INE901L01018 alembic-pharmaceuticals-ltd 'Alembic Pharmaceuticals' '496.05'

Alembic Pharmaceuticals Financial Results

Alembic Pharmaceuticals NSE

496.05 00.00 (1.04%) Profit

High
498.35
Low
485.80
Open at
494.85
Prev Close
496.05
Pharmaceuticals

Lightning Fast Investing To view real-time data of Alembic Pharmaceuticals and trade with industry first features, Login or Open Free Demat Account. To view real-time data of Alembic Pharmaceuticals and trade with industry first features, Login or Open Free Demat Account.

Financials:

Revenue, Income Statement, Balance Sheet & Cash Flow

Income Statement

as of March 2022

Financial YearFY 2021-22FY 2020-21FY 2018-19FY 2017-18FY 2016-17
All Expenditure (Cr)4,431.633,912.853,061.102,487.722,519.34
Operating Profit (Cr)17.4329.0722.4420.770.00
EBIDTA (Cr)170.37345.64181.41173.87135.58
Profit Before Tax (Cr)625.391,368.08749.32541.26529.09
Tax (Cr)104.46253.32156.75120.36122.19
Net Income (Cr)5,399.445,674.354,036.333,179.903,177.12
EPS (Cr)26.5058.3331.0021.8921.39
DPS (Cr)0.000.000.000.000.00

Balance Sheet

as of March 2022

Equities & Liabilities

Financial YearFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Share Capital (Cr)39.3139.3137.7037.7037.70
Reserves & Surplus (Cr)5,198.235,027.663,181.712,681.122,182.44
Current Liabiltiies (Cr)1,269.261,157.591,051.361,001.351,055.10
Other Liabilities (Cr)95.8285.52147.8152.0340.76
Total Liabilities (Cr)6,050.475,736.105,085.753,898.502,968.99

Assets

Financial YearFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Fixed Assets4,102.083,970.953,398.022,709.682,003.53
Current Assets1,795.111,492.171,559.451,078.47852.68
Other Assets3,564.593,795.792,953.082,435.801,702.54
Total Assets34.8836.70110.6661.5971.14

Cash Flows

as of March 2022

Financial YearFY 2021-22FY 2020-21FY 2018-19FY 2017-18FY 2016-17
Operating Activities (Cr)552.351,463.39811.96312.42328.55
Investing Activities (Cr)-371.97-839.74-755.67-884.38-485.91
Financing Activities (Cr)-217.35-597.4359.04502.63-128.88
Others (Cr)79.59-2.72-1.18-4.820.00
Net Cash Flow (Cr)-36.9726.22115.33-69.33-286.24

Alembic Pharmaceuticals Financial Statements Overview

Alembic Pharmaceuticals financial statements offers an overview of the company's Revenue, Income Statement, Balance Statement, Cash Flows and more. It helps to analyse the company's financial position and its revenue to profit trend. Alembic Pharmaceuticals reported a Net Income of Rs. 5,399.44 and an Operating Profit of Rs. 17.43 in the . The Total Liabilities stood at Rs. 6,050.47 in the last year. The Earning Per Share (EPS) and Dividend Per Share (DPS) stood at Rs. 26.50 and Rs. 0.00 respectively. While, analysing Financial Statements of a company is crucial, it is equally important to look at the Share Price, Stock Performance, Fundamental Analysis, Technicals and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.


Download Dhan App

Ready to Trade & Invest in
Alembic Pharmaceuticals?

Get started in 10 minutes or less from here 👇

+91.


sec_id>